Clinical Trial Committee
Clinical Trials Technical Committee
The Clinical Trials Technical Committee (CTTC) has been established by Director General under Section 13 of TMDA Act, Cap 219 to provide independent technical advice to the Director General.
The CTTC provides technical advice to ensure that clinical trials are designed, conducted, analyzed and reported by TMDA and ICH guidelines. In this respect, their recommendations are expected to be scientific and evidence-based.
Members of the Clinical Trial Technical Committee (CTTC) are expected to be prudent, transparent, independent, and committed to their professional ethics while discussing all matters pertaining to clinical trials.
Composition of the Committee
The CTTC is composed of experts with knowledge and experience in at least any of the following fields: Clinical Trials, Medical Research, Clinical Pharmacology, Clinical Epidemiology, Medicine, Dental Surgery, Pharmacy, Medical Statistics, Public Health, Toxicology, Microbiology, Pathology and Regulatory Affairs
The CTTC meets once quarterly and the current members are as listed in the table;
|1.||Dr. Doreen Mloka||Chair Person||Pharmaceutical Microbiology|
|2.||Dr. Yonah H. Mwalwisi||Secretary||Pharmacy and Regulatory Affairs|
|3.||Dr. Billy Ngasala||Member||Parasitology and Medical Entomology|
|4.||Prof. Mecky Matee||Member||Microbiology|
|5.||Dr. Omar Lweno||Member||Epidemiology/ Clinical Trials|
|6.||Dr. Jenifa Metodi||Member||Paediatrics|
|7.||Dr. Mwanaidi Kafuye||Member||Research ethics/ Immunology and microbiology|
|8.||Dr. Hadija Malima||Member||Research ethics/ Epidemiology|
|9.||Prof. Patricia Munseri||Member||Internal Medicine /Clinical Trials|
The Committee serves for three (3) years and the tenure of the current Committee will come to an end on 31st January, 2025.